CHEK2*1100delC homozygosity in the Netherlands—prevalence and risk of breast and lung cancer

The 1100delC mutation in the CHEK2 gene has a carrier frequency of up to 1.5% in individuals from North-West Europe. Women heterozygous for 1100delC have an increased breast cancer risk (odds ratio 2.7). To explore the prevalence and clinical consequences of 1100delC homozygosity in the Netherlands,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Huijts, Petra EA, Hollestelle, Antoinette, Balliu, Brunilda, Houwing-Duistermaat, Jeanine J, Meijers, Caro M, Blom, Jannet C, Ozturk, Bahar, Krol-Warmerdam, Elly MM, Wijnen, Juul, Berns, Els MJJ, Martens, John WM, Seynaeve, Caroline, Kiemeney, Lambertus A, van der Heijden, Henricus F, Tollenaar, Rob AEM, Devilee, Peter, van Asperen, Christi J
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3865411/
https://ncbi.nlm.nih.gov/pubmed/23652375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ejhg.2013.85
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars